-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Protalix BioTherapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2011 to Q3 2024.
- Protalix BioTherapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 81.2M shares, a 3.06% decline year-over-year.
- Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 82.4M shares, a 70% increase from 2022.
- Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 48.5M shares, a 9.81% increase from 2021.
- Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 44.1M shares, a 51.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)